Bruno Ledergerber
#152,906
Most Influential Person Now
Researcher
Bruno Ledergerber's AcademicInfluence.com Rankings
Bruno Ledergerbercomputer-science Degrees
Computer Science
#8183
World Rank
#8605
Historical Rank
Machine Learning
#3274
World Rank
#3313
Historical Rank
Artificial Intelligence
#3577
World Rank
#3628
Historical Rank
Database
#5205
World Rank
#5405
Historical Rank
Download Badge
Computer Science
Bruno Ledergerber's Degrees
- PhD Computer Science ETH Zurich
- Masters Computer Science ETH Zurich
- Bachelors Computer Science ETH Zurich
Similar Degrees You Can Earn
Why Is Bruno Ledergerber Influential?
(Suggest an Edit or Addition)Bruno Ledergerber's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies (2002) (1630)
- Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection (2008) (1539)
- Decline in the AIDS and death rates in the EuroSIDA study: an observational study (2003) (1279)
- A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1 (2007) (1258)
- Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. (2006) (1217)
- Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study (1999) (989)
- Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study (2000) (982)
- Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies (2009) (806)
- Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. (2011) (586)
- Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study (2005) (585)
- Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. (2010) (577)
- Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort (2005) (573)
- AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. (1999) (524)
- Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals (2012) (462)
- Common Genetic Variation and the Control of HIV-1 in Humans (2009) (448)
- Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group. (1999) (417)
- CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. (2003) (410)
- Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy. (2005) (402)
- Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients (2010) (393)
- Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study (2001) (363)
- Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study (2013) (351)
- Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy. (2005) (326)
- HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. (2001) (322)
- Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes (2004) (318)
- Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies (2007) (315)
- Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study (2010) (271)
- Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies (2003) (268)
- Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study (1999) (261)
- Serious Fatal and Nonfatal Non-AIDS-Defining Illnesses in Europe (2010) (261)
- Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study (2007) (255)
- Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study. (2007) (253)
- Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection (1999) (236)
- Cohort profile: the Swiss HIV Cohort study. (2010) (204)
- Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy. (2004) (198)
- High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients (2010) (193)
- Prevalence of comedications and effect of potential drug–drug interactions in the Swiss HIV Cohort Study (2010) (189)
- Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups. (2001) (182)
- Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland. (2010) (175)
- Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe. (2008) (166)
- Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008. (2010) (157)
- The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy. (2005) (155)
- A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection. (2002) (150)
- Changes in Inflammatory and Coagulation Biomarkers: A Randomized Comparison of Immediate versus Deferred Antiretroviral Therapy in Patients With HIV Infection (2011) (149)
- Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey (2007) (148)
- Public-Health and Individual Approaches to Antiretroviral Therapy: Township South Africa and Switzerland Compared (2008) (146)
- Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy. (2002) (145)
- Enteric infections and diarrhea in human immunodeficiency virus-infected persons: prospective community-based cohort study. Swiss HIV Cohort Study. (1999) (142)
- Safe Interruption of Maintenance Therapy against Previous Infection with Four Common HIV-Associated Opportunistic Pathogens during Potent Antiretroviral Therapy (2002) (140)
- Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count > 350 × 106/l (2002) (139)
- Ambiguous Nucleotide Calls From Population-based Sequencing of HIV-1 are a Marker for Viral Diversity and the Age of Infection (2011) (139)
- Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study. (2009) (137)
- Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types. (2007) (136)
- A clinically prognostic scoring system for patients receiving highly active antiretroviral therapy: results from the EuroSIDA study. (2002) (134)
- Quantitative Antibiotic Use in Hospitals: Comparison of Measurements, Literature Review, and Recommendations for a Standard of Reporting (2008) (134)
- Determinants of HIV-1 broadly neutralizing antibody induction (2016) (124)
- Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population (2003) (123)
- Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders. (2005) (121)
- Role of retroviral restriction factors in the interferon-α–mediated suppression of HIV-1 in vivo (2012) (118)
- ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir (2010) (113)
- Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study. (2008) (113)
- Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection. (2010) (113)
- Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacin (1985) (112)
- Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing (2014) (112)
- Association of pharmacogenetic markers with premature discontinuation of first-line anti-HIV therapy: an observational cohort study. (2011) (109)
- Different Patterns of Inappropriate Antimicrobial Use in Surgical and Medical Units at a Tertiary Care Hospital in Switzerland: A Prevalence Survey (2010) (108)
- Molecular evidence of interhuman transmission in an outbreak of Pneumocystis jirovecii pneumonia among renal transplant recipients (2010) (108)
- Virological rebound after suppression on highly active antiretroviral therapy (2003) (108)
- Progression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadone. (1990) (107)
- Comparison of high-pressure liquid chromatography and bioassay for determination of ciprofloxacin in serum and urine (1985) (104)
- Factors associated with rifampin resistance in staphylococcal periprosthetic joint infections (PJI): a matched case–control study (2013) (101)
- Higher CNS Penetration-Effectiveness of Long-term Combination Antiretroviral Therapy Is Associated With Better HIV-1 Viral Suppression in Cerebrospinal Fluid (2013) (99)
- Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort study. (2010) (97)
- Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival (2003) (95)
- Is the virulence of HIV changing? A meta-analysis of trends in prognostic markers of HIV disease progression and transmission (2012) (90)
- Factors associated with the development of opportunistic infections in HIV-1-infected adults with high CD4+ cell counts: a EuroSIDA study. (2006) (89)
- Survival differences in European patients with AIDS, 1979–89 (1994) (89)
- The HIV care cascade in Switzerland: reaching the UNAIDS/WHO targets for patients diagnosed with HIV (2015) (88)
- Time to virological failure of 3 classes of antiretrovirals after initiation of highly active antiretroviral therapy: results from the EuroSIDA study group. (2004) (87)
- Causality, mediation and time: a dynamic viewpoint (2012) (87)
- Viral load outcome of non-nucleoside reverse transcriptase inhibitor regimens for 2203 mainly antiretroviral-experienced patients (2001) (86)
- The Swiss HIV Cohort Study: Rationale, organization and selected baseline characteristics (2005) (85)
- Human immunodeficiency virus type 1 p24 concentration measured by boosted ELISA of heat-denatured plasma correlates with decline in CD4 cells, progression to AIDS, and survival: comparison with viral RNA measurement. (2000) (82)
- Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohort. (1999) (81)
- Uptake of and virological response to antiretroviral therapy among HIV‐infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study (2009) (81)
- Thymidine Analogue Mutation Profiles: Factors Associated with Acquiring Specific Profiles and their Impact on the Virological Response to Therapy (2005) (80)
- Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study Group. (1997) (79)
- Correlation between case mix index and antibiotic use in hospitals. (2008) (79)
- Effect of acetazolamide and autoCPAP therapy on breathing disturbances among patients with obstructive sleep apnea syndrome who travel to altitude: a randomized controlled trial. (2012) (79)
- Optimal Length of Cultivation Time for Isolation of Propionibacterium acnes in Suspected Bone and Joint Infections Is More than 7 Days (2016) (79)
- Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine (1994) (78)
- Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine (1994) (78)
- Effect of Individual Cognitive Behaviour Intervention on Adherence to Antiretroviral Therapy: Prospective Randomized Trial (2004) (77)
- Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study. (2014) (77)
- Effects of statins on endothelial function and lipid profile in HIV infected persons receiving protease inhibitor-containing anti-retroviral combination therapy: a randomised double blind crossover trial (2005) (76)
- HIV-1 coreceptor usage and CXCR4-specific viral load predict clinical disease progression during combination antiretroviral therapy (2008) (75)
- The role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland. (2011) (74)
- Resurgence of HIV Infection among Men Who Have Sex with Men in Switzerland: Mathematical Modelling Study (2012) (72)
- Association of virus load, CD4 cell count, and treatment with clinical progression in human immunodeficiency virus-infected patients with very low CD4 cell counts. (2002) (71)
- Retinal and extraocular cytomegalovirus end-organ disease in HIV-infected patients in Europe: a EuroSIDA study, 1994–2001 (2004) (70)
- Systemic antibody responses to gut commensal bacteria during chronic HIV-1 infection (2011) (69)
- Estimating Loss to Follow-Up in HIV-Infected Patients on Antiretroviral Therapy: The Effect of the Competing Risk of Death in Zambia and Switzerland (2011) (67)
- Risk of AIDS and death at given HIV-RNA and CD4 cell count, in relation to specific antiretroviral drugs in the regimen (2005) (66)
- Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012. (2015) (66)
- Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B. (2011) (63)
- A sequential Cox approach for estimating the causal effect of treatment in the presence of time‐dependent confounding applied to data from the Swiss HIV Cohort Study (2010) (63)
- Regional differences in use of antiretroviral agents and primary prophylaxis in 3122 European HIV-infected patients. EuroSIDA Study Group. (1997) (62)
- Machine learning can identify newly diagnosed patients with CLL at high risk of infection (2020) (60)
- Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort Study (2014) (58)
- Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort Study (2014) (58)
- Stable virulence levels in the HIV epidemic of Switzerland over two decades (2006) (56)
- Importance of Mental Health Assessment in HIV‐Infected Outpatients (2001) (55)
- Risks Factors for Infections with Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae at a Tertiary Care University Hospital in Switzerland (2010) (55)
- Impact of occasional short interruptions of HAART on the progression of HIV infection: results from a cohort study (2002) (55)
- Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland. (2009) (55)
- Emergence of Acquired HIV-1 Drug Resistance Almost Stopped in Switzerland: A 15-Year Prospective Cohort Analysis. (2016) (53)
- HIV-1 Transmission During Recent Infection and During Treatment Interruptions as Major Drivers of New Infections in the Swiss HIV Cohort Study. (2016) (53)
- Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir. (2008) (53)
- Sex differences in HIV-1 viral load and progression to AIDS (1999) (52)
- Survival in HIV infection: do sex and category of transmission matter? (1994) (52)
- Reasons for late presentation to HIV care in Switzerland (2015) (51)
- Stratification of cumulative antibiograms in hospitals for hospital unit, specimen type, isolate sequence and duration of hospital stay. (2008) (51)
- CD 4 T-Lymphocyte Recovery in Individuals With Advanced HIV-1 Infection Receiving Potent Antiretroviral Therapy for 4 Years The Swiss HIV Cohort Study (2003) (50)
- Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy The Swiss HIV Cohort Study (2001) (50)
- Impact of Lamivudine on the Risk of Liver-Related Death in 2,041 Hbsag- and HIV-Positive Individuals: Results from an Inter-Cohort Analysis (2006) (49)
- Contribution of Genome-Wide Significant Single-Nucleotide Polymorphisms and Antiretroviral Therapy to Dyslipidemia in HIV-Infected Individuals: A Longitudinal Study (2009) (49)
- Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score (2007) (49)
- HIV Cohort Collaborations: Proposal for Harmonization of Data Exchange (2004) (47)
- Strong Impact of Smoking on Multimorbidity and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Individuals in Comparison With the General Population (2015) (46)
- Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years. (2010) (46)
- Relationship between antiretrovirals used as part of a cART regimen and CD4 cell count increases in patients with suppressed viremia (2006) (46)
- Effects of cognitive behavioral stress management on HIV-1 RNA, CD4 cell counts and psychosocial parameters of HIV-infected persons (2008) (46)
- Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients (2007) (45)
- Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients (2007) (45)
- Outcome of smoking cessation counselling of HIV‐positive persons by HIV care physicians (2012) (45)
- Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs study. (2013) (45)
- Randomized, placebo-controlled trial of Chinese herb therapy for HIV-1-infected individuals. (1999) (44)
- Frequency of and Risk Factors for Depression among Participants in the Swiss HIV Cohort Study (SHCS) (2015) (44)
- Rates of disease progression according to initial highly active antiretroviral therapy regimen: a collaborative analysis of 12 prospective cohort studies. (2006) (44)
- Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study. (2012) (43)
- Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs (2016) (43)
- Hepatitis C Virus Coinfection Does Not Influence the CD4 Cell Recovery in HIV-1-Infected Patients With Maximum Virologic Suppression (2009) (43)
- Effect of atazanavir versus other protease inhibitor-containing antiretroviral therapy on endothelial function in HIV-infected persons: randomised controlled trial (2008) (43)
- Long-term exposure to combination antiretroviral therapy and risk of death from specific causes: no evidence for any previously unidentified increased risk due to antiretroviral therapy (2012) (43)
- Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. AIDS in Europe Study Group. (1994) (43)
- Subclinical coronary artery disease in Swiss HIV-positive and HIV-negative persons (2018) (42)
- Causes of death in HIV infection: the key determinant to define the clinical response to anti-HIV therapy (2004) (42)
- Weight and Metabolic Changes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living With HIV (2021) (42)
- Infection‐related and ‐unrelated malignancies, HIV and the aging population (2016) (41)
- Intestinal infection due to enteroaggregative Escherichia coli among human immunodeficiency virus-infected persons. (2000) (41)
- HIV-1 p24 antigen is a significant inverse correlate of CD4 T-cell change in patients with suppressed viremia under long-term antiretroviral therapy. (2003) (41)
- Levels of HIV‐infected peripheral blood cells remain stable throughout the natural history of HIV‐1 infection (1998) (41)
- Eligibility for and Outcome of Hepatitis C Treatment of HIV-Coinfected Individuals in Clinical Practice: The Swiss HIV Cohort Study (2006) (41)
- Risk factors for and outcome of hyperlactatemia in HIV-infected persons: is there a need for routine lactate monitoring? (2005) (41)
- HBV or HCV Coinfections and Risk of Myocardial Infarction in HIV-Infected Individuals: The D:A:D Cohort Study (2010) (41)
- Choice of Initial Combination Antiretroviral Therapy in Individuals With HIV Infection: Determinants and Outcomes. (2012) (41)
- Quantification of In Vivo Replicative Capacity of HIV‐1 in Different Compartments of Infected Cells (2001) (41)
- Discontinuing or withholding primary prophylaxis against Mycobacterium avium in patients on successful antiretroviral combination therapy. The Swiss HIV Cohort Study (2000) (40)
- Higher rates of triple‐class virological failure in perinatally HIV‐infected teenagers compared with heterosexually infected young adults in Europe (2016) (40)
- Use of HIV-1 p24 as a sensitive, precise and inexpensive marker for infection, disease progression and treatment failure. (2000) (40)
- African descent is associated with slower CD4 cell count decline in treatment-naive patients of the Swiss HIV Cohort Study (2009) (40)
- Cost-Effectiveness of Genotypic Antiretroviral Resistance Testing in HIV-Infected Patients with Treatment Failure (2007) (39)
- Participation, characteristics and retention rates of HIV‐positive immigrants in the Swiss HIV Cohort Study * (2012) (39)
- HIV-1 reverse transcriptase connection domain mutations: dynamics of emergence and implications for success of combination antiretroviral therapy. (2010) (39)
- Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations. (2012) (39)
- High hepatic and extrahepatic mortality and low treatment uptake in HCV-coinfected persons in the Swiss HIV cohort study between 2001 and 2013. (2015) (39)
- Clustering of HCV coinfections on HIV phylogeny indicates domestic and sexual transmission of HCV. (2014) (39)
- Multidrug-resistant bacteria in travellers hospitalized abroad: prevalence, characteristics, and influence on clinical outcome. (2012) (37)
- [Epidemiology of HIV]. (2014) (37)
- Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics. (2012) (37)
- Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovir (2005) (36)
- Prevalence of etravirine mutations and impact on response to treatment in routine clinical care: the Swiss HIV Cohort Study (SHCS) (2009) (35)
- Antiretroviral treatment and osteonecrosis in patients of the Swiss HIV Cohort Study: a nested case-control study. (2004) (35)
- History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change * (2010) (35)
- Co-Trimoxazole Prophylaxis Is Associated with Reduced Risk of Incident Tuberculosis in Participants in the Swiss HIV Cohort Study (2014) (35)
- Hepatitis C virus and non-Hodgkin's lymphoma: findings from the Swiss HIV Cohort Study (2006) (35)
- Delayed Sputum Culture Conversion in Tuberculosis–Human Immunodeficiency Virus–Coinfected Patients With Low Isoniazid and Rifampicin Concentrations (2018) (35)
- Switching from protease inhibitors to efavirenz: differences in efficacy and tolerance among risk groups: a case–control study from the Swiss HIV Cohort (2002) (35)
- A Standardized Algorithm for Determining the Underlying Cause of Death in HIV Infection as AIDS or non-AIDS Related: Results from the EuroSIDA Study (2011) (34)
- Risk factors for tuberculosis among HIV-infected patients in Switzerland. Swiss HIV Cohort Study. (1996) (34)
- Neighbourhood socio-economic position, late presentation and outcomes in people living with HIV in Switzerland (2015) (34)
- Rate of viral rebound according to specific drugs in the regimen in 2120 patients with HIV suppression (2004) (33)
- Epidemiological and biological evidence for a compensatory effect of connection domain mutation N348I on M184V in HIV-1 reverse transcriptase. (2010) (33)
- Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection (2000) (33)
- Influence of noninjecting and injecting drug use on mortality, retention in the cohort, and antiretroviral therapy, in participants in the Swiss HIV Cohort Study (2015) (33)
- Risk factors for urinary tract infections due to ciprofloxacin-resistant Escherichia coli in a tertiary care urology department in Switzerland. (2010) (33)
- Are Specific Antiretrovirals associated with an Increased Risk of Discontinuation due to Toxicities or Patient/Physician Choice in patients with Hepatitis C Virus Coinfection? (2005) (33)
- Effects of Alpha Interferon Treatment on Intrinsic Anti-HIV-1 Immunity In Vivo (2013) (32)
- HIV-associated non-Hodgkin's lymphoma: highly active antiretroviral therapy improves remission rate of chemotherapy. (1999) (32)
- Impact of single nucleotide polymorphisms and of clinical risk factors on new‐onset diabetes mellitus in HIV‐infected individuals. (2010) (32)
- Impact of Genotypic Resistance Testing on Selection of Salvage Regimen in Clinical Practice (2002) (32)
- Quality of life in asymptomatic patients with early HIV infection initiating antiretroviral therapy. Swiss HIV Cohort Study. (1999) (32)
- Changes in Viral Load in People with Virological Failure who Remain on the Same Haart Regimen (2002) (31)
- High Cure Rates With Grazoprevir-Elbasvir With or Without Ribavirin Guided by Genotypic Resistance Testing Among Human Immunodeficiency Virus/Hepatitis C Virus–coinfected Men Who Have Sex With Men (2018) (31)
- Population pharmacokinetic modelling and evaluation of different dosage regimens for darunavir and ritonavir in HIV-infected individuals. (2014) (31)
- Regional survival differences across Europe in HIV-positive people: the EuroSIDA study. (1999) (29)
- Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study (2016) (29)
- A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected men. (2007) (29)
- Hepatitis C Infection and the Risk of Non-Liver-Related Morbidity and Mortality in HIV-Infected Persons in the Swiss HIV Cohort Study (2016) (29)
- HIV testing history and access to treatment among migrants living with HIV in Europe (2018) (28)
- Antibiotic susceptibility of Clostridium difficile is similar worldwide over two decades despite widespread use of broad-spectrum antibiotics: an analysis done at the University Hospital of Zurich (2014) (28)
- Factors Associated with Low-Level Viraemia and Virological Failure: Results from the Austrian HIV Cohort Study (2015) (27)
- High Rates of Subsequent Asymptomatic Sexually Transmitted Infections and Risky Sexual Behavior in Patients Initially Presenting With Primary Human Immunodeficiency Virus-1 Infection (2018) (27)
- CD4/CD8 ratio and CD8 counts predict CD4 response in HIV-1-infected drug naive and in patients on cART (2016) (26)
- The role of FDG PET/CT in therapy control of aortic graft infection (2018) (25)
- A comparison of the long‐term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe: a EuroSIDA study (2011) (25)
- Tuberculosis among European patients with the acquired immune deficiency syndrome. The AIDS in Europe Study Group. (1996) (24)
- The EuroSIDA study: 25 years of scientific achievements (2019) (24)
- Changes in survival over time after a first episode of Pneumocystis carinii pneumonia for european patients with acquired immunodeficiency syndrome (1995) (23)
- Changes in survival over time after a first episode of Pneumocystis carinii pneumonia for european patients with acquired immunodeficiency syndrome (1995) (23)
- Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study. (2010) (23)
- A highly virulent variant of HIV-1 circulating in the Netherlands (2022) (23)
- A treatment as prevention trial to eliminate hepatitis C among men who have sex with men living with HIV in the Swiss HIV Cohort Study. (2020) (23)
- Implementation of Raltegravir in Routine Clinical Practice: Selection Criteria for Choosing This Drug, Virologic Response Rates, and Characteristics of Failures (2010) (22)
- Comparing diagnostic accuracy of 18F-FDG-PET/CT, contrast enhanced CT and combined imaging in patients with suspected vascular graft infections (2018) (22)
- Impact of Previous Virological Treatment Failures and Adherence on the Outcome of Antiretroviral Therapy in 2007 (2009) (21)
- Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing Regimens (2012) (21)
- The DAD Study Group. Combination antiretroviral therapy and the risk of myocardial infarction (2003) (21)
- Outcomes of Antiretroviral Therapy in the Swiss HIV Cohort Study: Latent Class Analysis (2012) (20)
- Minor Protease Inhibitor Mutations at Baseline Do Not Increase the Risk for a Virological Failure in HIV-1 Subtype B Infected Patients (2012) (20)
- Estimating HIV prevalence in Switzerland. (1993) (20)
- Antiretroviral prophylaxis for community exposure to the human immunodeficiency virus in Switzerland, 1997-2000. (2001) (19)
- Initial management of and outcome in patients with pneumococcal bacteremia: a retrospective study at a Swiss university hospital, 2003–2009 (2011) (19)
- A Single Quantifiable Viral Load Is Predictive of Virological Failure in Human Immunodeficiency Virus (HIV)-Infected Patients on Combination Antiretroviral Therapy: The Austrian HIV Cohort Study (2016) (19)
- Lymphocyte Count Kinetics, Factors Associated with the End of Radiotherapy Lymphocyte Count and Risk of Infection in Patients with Solid Malignant Tumors treated with Curative Intent Radiotherapy. (2019) (19)
- A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients (2015) (18)
- Prevalence and risk factors of late presentation for HIV diagnosis and care in a tertiary referral centre in Switzerland. (2014) (18)
- The effects of HIV-1 subtype and ethnicity on the rate of CD4 cell count decline in patients naive to antiretroviral therapy: a Canadian-European collaborative retrospective cohort study. (2014) (18)
- Diagnostic Accuracy of PET/CT and Contrast Enhanced CT in Patients With Suspected Infected Aortic Aneurysms. (2020) (18)
- Diagnostic Accuracy of PET/CT and Contrast Enhanced CT in Patients With Suspected Infected Aortic Aneurysms. (2020) (18)
- Trends over time of virological and immunological characteristics in the Swiss HIV Cohort Study * (2011) (18)
- Calendar Time Trends in the Incidence and Prevalence of Triple-Class Virologic Failure in Antiretroviral Drug-Experienced People With HIV in Europe (2011) (18)
- Quantification of in vivo replicative capacity of HIV-1 in different compartments of infected cells. (2001) (17)
- Barriers to health care services for migrants living with HIV in Spain (2018) (17)
- Long-term Immune Response to Yellow Fever Vaccination in Human Immunodeficiency Virus (HIV)–Infected Individuals Depends on HIV RNA Suppression Status: Implications for Vaccination Schedule (2018) (17)
- Cobas Ampliprep/Cobas TaqMan HIV-1 v2.0 Assay: Consequences at the Cohort Level (2013) (17)
- Stability of hepatitis C virus (HCV) RNA levels among interferon‐naïve HIV/HCV‐coinfected individuals treated with combination antiretroviral therapy (2013) (17)
- HAART and the heart: changes in coronary risk factors and implications for coronary risk in men starting antiretroviral therapy (2007) (17)
- Viral Suppression Rates in Salvage Treatment With Raltegravir Improved With the Administration of Genotypic Partially Active or Inactive Nucleoside/Tide Reverse Transcriptase Inhibitors (2011) (16)
- Increased mortality after a first myocardial infarction in human immunodeficiency virus-infected patients; a nested cohort study (2015) (16)
- Changing Trends in International Versus Domestic HCV Transmission in HIV-Positive Men Who Have Sex With Men: A Perspective for the Direct-Acting Antiviral Scale-Up Era (2019) (16)
- High Number of Potential Transmitters Revealed in a Population-based Systematic Hepatitis C Virus RNA Screening Among Human Immunodeficiency Virus-infected Men Who Have Sex With Men (2019) (16)
- Changes in renal function after switching from TDF to TAF in HIV-infected individuals: a prospective cohort study. (2020) (16)
- Analyzing direct and indirect effects of treatment using dynamic path analysis applied to data from the Swiss HIV Cohort Study (2011) (16)
- Changes in survival over time after a first episode of Pneumocystis carinii pneumonia for European patients with acquired immunodeficiency syndrome. Multicentre Study Group on AIDS in Europe. (1995) (15)
- Treatment modification in HIV-Infected individuals starting antiretroviral therapy between 2011 and 2014 (2014) (15)
- Viral Diversity Based on Next-Generation Sequencing of HIV-1 Provides Precise Estimates of Infection Recency and Time Since Infection. (2019) (15)
- CD4 count and viral load specific rates of AIDS, non‐AIDS and deaths according to current antiretroviral use (2012) (15)
- Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis (2017) (15)
- Genotypic Resistance Tests Sequences Reveal the Role of Marginalized Populations in HIV-1 Transmission in Switzerland (2016) (15)
- Estimated average annual rate of change of CD4+ T-cell counts in patients on combination antiretroviral therapy (2010) (15)
- Higher risk of incident hepatitis C virus coinfection among men who have sex with men, in whom the HIV genetic bottleneck at transmission was wide. (2014) (15)
- Long-term efficacy after switch from protease inhibitor-containing highly active antiretroviral therapy to abacavir, lamivudine, and zidovudine. (2004) (14)
- Enteric Infections and Diarrhea in Human Immunodeficiency VirusInfected Persons: Prospective Community-Based Cohort Study (1999) (14)
- A stringent preemptive protocol reduces cytomegalovirus disease in the first 6 months after kidney transplantation (2012) (14)
- Long-Term Virological Response to Multiple Sequential Regimens of Highly Active Antiretroviral Therapy for HIV Infection (2004) (14)
- Population pharmacokinetics of dolutegravir: influence of drug-drug interactions in a real-life setting. (2019) (14)
- Anti-TB drug concentrations and drug-associated toxicities among TB/HIV-coinfected patients (2017) (14)
- 2 0 1 7 CD 4 / CD 8 ratio and CD 8 counts predict CD 4 response in HIV-1-infected drug naive and in patients on cART (2016) (14)
- Inadequate perioperative prophylaxis and postsurgical complications after graft implantation are important risk factors for subsequent vascular graft infections - prospective results from the VASGRA Cohort Study. (2018) (14)
- A Longitudinal Analysis of Healthcare Costs after Treatment Optimization following Genotypic Antiretroviral Resistance Testing: Does Resistance Testing pay off? (2005) (14)
- Repeated Syphilis Episodes in HIV-Infected Men Who Have Sex With Men: A Multicenter Prospective Cohort Study on Risk Factors and the Potential Role of Syphilis Immunity (2020) (13)
- No longitudinal mitochondrial DNA sequence changes in HIV-infected individuals with and without lipoatrophy. (2011) (13)
- Predicting smoking cessation and its relapse in HIV‐infected patients: the Swiss HIV Cohort Study (2015) (13)
- Dynamic models for estimating the effect of HAART on CD4 in observational studies: Application to the Aquitaine Cohort and the Swiss HIV Cohort Study (2015) (13)
- Predictive Cross‐validation for the Choice of Linear Mixed‐Effects Models with Application to Data from the Swiss HIV Cohort Study (2012) (12)
- Time to Switch to Second-line Antiretroviral Therapy in Children With Human Immunodeficiency Virus in Europe and Thailand (2018) (12)
- HIV-1 progression in hepatitis-C-infected drug users (2001) (12)
- Perioperative Antibiotic Prophylaxis Has No Effect on Time to Positivity and Proportion of Positive Samples: a Cohort Study of 64 Cutibacterium acnes Bone and Joint Infections (2017) (12)
- Heterogeneity in the Response to Antiretroviral Therapy (2001) (12)
- Computer-controlled in-vitro simulation of multiple dosing regimens. (1985) (12)
- Efficacy of etravirine combined with darunavir or other ritonavir‐boosted protease inhibitors in HIV‐1‐infected patients: an observational study using pooled European cohort data (2015) (11)
- Predictors of Virological Failure and Time to Viral Suppression of First-Line Integrase Inhibitor–Based Antiretroviral Treatment (2020) (11)
- Costs of treatment of Swiss patients with HIV on antiretroviral therapy in hospital-based and general practice-based care: a prospective cohort study (2005) (11)
- A Phylogenetic Analysis of Human Immunodeficiency Virus Type 1 Sequences in Kiev: Findings Among Key Populations (2017) (11)
- CCTTT‐repeat polymorphism of the inducible nitric oxide synthase is not associated with HIV pathogenesis (2004) (11)
- Clinical outcomes of two-drug regimens vs. three-drug regimens in antiretroviral treatment-experienced people living with HIV. (2020) (11)
- How reliable is an undetectable viral load? (2009) (11)
- Difference in factors associated with low-level viraemia and virological failure: results from the Austrian HIV Cohort Study (2014) (10)
- Baseline Resistance and Virological Outcome in Patients with Virological Failure who Start a Regimen Containing Abacavir: Eurosida Study (2004) (10)
- Lifetime Costs and Quality-Adjusted Life Years Saved From HIV Prevention in the Test and Treat Era (2013) (10)
- High efavirenz serum concentrations in TB/HIV-coinfected Ugandan adults with a CYP2B6 516 TT genotype on anti-TB treatment (2018) (10)
- Prevalence and predictors for homo- and heterosubtypic antibodies against influenza a virus. (2014) (10)
- PET/CT helps to determine treatment duration in patients with resected as well as inoperable alveolar echinococcosis. (2021) (10)
- Cytomegalovirus retinitis in patients with AIDS in Europe (1997) (9)
- Efficacy of lead‐in silibinin and subsequent triple therapy in difficult‐to‐treat HIV/hepatitis C virus‐coinfected patients (2014) (9)
- Antiretroviral Drugs Associated with Subclinical Coronary Artery Disease in the Swiss HIV Cohort Study. (2019) (9)
- Cohort profile of a study on outcomes related to tuberculosis and antiretroviral drug concentrations in Uganda: design, methods and patient characteristics of the SOUTH study (2017) (9)
- Emergence of drug resistance in the Swiss HIV Cohort Study under potent antiretroviral therapy is observed in socially disadvantaged patients. (2019) (9)
- Viral toad changes in response to antiretroviral therapy according to the baseline CD4 lymphocyte count and viral load (2000) (9)
- Associations Between Antiretroviral Treatment and Avascular Bone Necrosis: The Swiss HIV Cohort Study (2017) (9)
- Predictors for the emergence of the 2 multi-nucleoside/nucleotide resistance mutations 69 insertion and Q151M and their impact on clinical outcome in the Swiss HIV cohort study. (2011) (9)
- Associations Between Antiretroviral Treatment and Avascular Bone Necrosis: The Swiss HIV Cohort Study (2017) (9)
- Polymorphic Mutations Associated With the Emergence of the Multinucleoside/Tide Resistance Mutations 69 Insertion and Q151M (2012) (8)
- Hematological toxicity in patients with solid malignant tumors treated with radiation - temporal analysis, dose response and impact on survival. (2021) (8)
- Importance of routine viral load monitoring: higher levels of resistance at ART failure in Uganda and Lesotho compared with Switzerland (2018) (8)
- Role of MicroRNA Modulation in the Interferon-α/Ribavirin Suppression of HIV-1 In Vivo (2014) (8)
- Analysis of inappropriate prescribing in elderly patients of the Swiss HIV Cohort Study reveals gender inequity. (2020) (8)
- Contribution of Genetic Background and Data Collection on Adverse Events of Anti–human Immunodeficiency Virus (HIV) Drugs (D:A:D) Clinical Risk Score to Chronic Kidney Disease in Swiss HIV-infected Persons With Normal Baseline Estimated Glomerular Filtration Rate (2019) (7)
- The Cumulative Impact of Harm Reduction on the Swiss HIV Epidemic: Cohort Study, Mathematical Model, and Phylogenetic Analysis (2018) (7)
- Predictors of CD4(+) T-cell counts of HIV type 1-infected persons after virologic failure of all 3 original antiretroviral drug classes. (2013) (7)
- Cotrimoxazole prophylaxis is associated with reduced risk of incident tuberculosis in participants in the Swiss HIV Cohort Study (2014) (7)
- Children and young people with perinatal HIV in Europe: epidemiological situation in 2014 and implications for the future (2016) (7)
- Effect of Hepatitis C Treatment on Cd4+ T-C El L Counts And The Risk Of Death In HIV–HCV-Coinfected Patients: The Cohere Collaboration (2012) (7)
- No Effect of Pegylated Interferon-&agr; on Total HIV-1 DNA Load in HIV-1/HCV Coinfected Patients (2018) (6)
- Nucleoside analogue use before and during highly active antiretroviral therapy and virus load rebound. (2004) (6)
- The influence of human genetic variation on Epstein–Barr virus sequence diversity (2021) (6)
- Reasons for not starting antiretroviral therapy in HIV-1-infected individuals: a changing landscape (2016) (6)
- Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study. (2015) (6)
- Comparison of Löwenstein–Jensen and BACTEC MGIT 960 culture for Mycobacterium tuberculosis in people living with HIV (2018) (6)
- Real-life management of drug-drug interactions between antiretrovirals and statins. (2020) (6)
- Pilot of the CoDe (Coding of Death) Project: A Standardized approach to code causes of death in HIV Infected individuals (2005) (6)
- Effect of Standard Breakfast on Drug Absorption and Multiple-Dose Pharmacokinetics of Ciprofloxacin (1985) (6)
- A Systematic Phylogenetic Approach to Study the Interaction of HIV-1 With Coinfections, Noncommunicable Diseases, and Opportunistic Diseases. (2019) (6)
- Differences in progression of HIV infection between men and women (1995) (5)
- Telomere Length, Traditional Risk Factors, HIV-related Factors and Coronary Artery Disease Events in Swiss Persons Living with HIV. (2020) (5)
- Ribavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort Study (2015) (5)
- Protease inhibitors to treat hepatitis C in the Swiss HIV Cohort Study: high efficacy but low treatment uptake (2015) (5)
- Accounting for baseline differences and measurement error in the analysis of change over time (2014) (5)
- Erratum: Impact of lamivudine on the risk of liver-related death in 2,041 HBsAg- and HIV-positive individuals: Results from an inter-cohort analysis (Antiviral Therapy (2006) 11 (657-674)) (2006) (5)
- Contribution of genetic background and clinical D:A:D risk score to chronic kidney disease in Swiss HIV-positive persons with normal baseline estimated glomerular filtration rate. (2019) (5)
- Smoking prevalence, cessation rates and relapse rates in the Swiss HIV Cohort Study (SHCS) (2010) (5)
- Hepatitis C infection and the risk of non-liver-related morbidity and mortality in HIV-positive persons in the Swiss HIV Cohort Study. (2016) (5)
- Why do sub‐Saharan Africans present late for HIV care in Switzerland? (2019) (5)
- [HIV infection, tuberculosis and tuberculin test in Switzerland. The Swiss HIV Cohort Study]. (1996) (5)
- Contribution of Genetic Background and Clinical Risk Factors to Low-Trauma Fractures in Human Immunodeficiency Virus (HIV)-Positive Persons: The Swiss HIV Cohort Study (2016) (5)
- 10th Conference on Retroviruses and Opportunistic Infections 2003 Boston, USA (2003) (5)
- Validation of the Management of Aortic Graft Infection Collaboration (MAGIC) Criteria for the Diagnosis of Vascular Graft/Endograft Infection: Results from the Prospective Vascular Graft Cohort Study. (2021) (5)
- Estimating the treatment effect on the treated under time‐dependent confounding in an application to the Swiss HIV Cohort Study (2016) (5)
- SOCIAL COST OF HIV INFECTION IN SWITZERLAND FINAL REPORT (5)
- Longitudinal Progression of Subclinical Coronary Atherosclerosis in Swiss HIV-Positive Compared With HIV-Negative Persons Undergoing Coronary Calcium Score Scan and CT Angiography (2020) (4)
- Longitudinal Progression of Subclinical Coronary Atherosclerosis in Swiss HIV-Positive Compared With HIV-Negative Persons Undergoing Coronary Calcium Score Scan and CT Angiography (2020) (4)
- Response to Calcagno comment on "Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid". (2013) (4)
- PET/CT in therapy control of infective native aortic aneurysms (2021) (4)
- Rapid Progression of Kidney Dysfunction in People Living With HIV: Use of Polygenic and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Risk Scores (2020) (4)
- Rapid Progression of Kidney Dysfunction in People Living With HIV: Use of Polygenic and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Risk Scores (2020) (4)
- Noncirrhotic portal hypertension and didanosine: a re-analysis. (2011) (4)
- Estimating the treatment effect of the treated under time-dependent confounding - applied to simulated data and to data from the Swiss HIV Cohort Study (2016) (4)
- The IeDEA Data Exchange Standard: a common data model for global HIV cohort collaboration (2020) (3)
- Association between resistance and CD4-count change in patients on ART with ongoing viraemia (2007) (3)
- Poverty and prognosis of HIV infection in Switzerland. Swiss HIV Cohort Study. (1998) (3)
- Incidental Findings on Coronary Computed Tomography Angiography in Human Immunodeficiency Virus (HIV)-Positive and HIV-Negative Persons (2018) (3)
- Rapid Progression of Kidney Dysfunction in Swiss People Living with HIV: Contribution of Polygenic Risk Score and D:A:D Clinical Risk Score. (2020) (3)
- Stringent adherence to a cytomegalovirus‐prevention protocol is associated with reduced overall costs in the first 6 months after kidney transplantation (2015) (3)
- Effects of HMG-CoA Reductase Inhibition on Endothelial Function and Lipid Profile in HIV-infected Persons on Protease Inhibitor-containing Antiretroviral Combination Therapy : A Randomized Double-Blind Cross-Over Trial (2005) (3)
- Phylogenetic Cluster Analysis Identifies Virological and Behavioral Drivers of Human Immunodeficiency Virus Transmission in Men Who Have Sex With Men (2020) (3)
- Dynamic versus marginal structural models for estimating the effect of HAART on CD4 in observational studies : application to the Aquitaine Cohort study and the Swiss HIV Cohort Study (2015) (2)
- Comparison of High-Pressure Liquid Chromatography (2)
- Delayed sputum conversation in TB-HIV co-infected patients with low isoniazid and rifampicin concentrations (2017) (2)
- Neurocognitive course at 2-year follow-up in a Swiss cohort of people with well-treated HIV (2021) (2)
- VIRAL REPLICATION AND LONG-TERM CLINICAL PROGRESSION IN PATIENTS TREATED WITH POTENT ANTIRETROVIRAL THERAPY (2002) (2)
- Emtricitabine and lamivudine concentrations in saliva: a simple suitable test for treatment adherence. (2019) (2)
- Compliance and laboratory data predict relapse rate of pneumocystis carinii pneumonia during prophylaxis with aerosol pentamidine (1990) (2)
- Construction and validation of a prognostic model for progression to AIDS or death in drug-naïve patients starting potent antiretroviral therapy. ART Cohort Collaboration (2002) (2)
- Prevalence of HIV antibodies in groups at risk in Zürich, Switzerland (1987) (2)
- International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK (2016) (2)
- [Sex differences in disease course: analysis of the Swiss HIV cohort study]. (1996) (2)
- Heritability of the HIV-1 reservoir size and decay under long-term suppressive ART (2020) (2)
- Age-and Sex-specific Death Rates in ART-naïve Patients with CD4 Count above 350 cells/m³ Compared with the General Population (2008) (2)
- O212 Rate of change in CD4 counts in patients with stable HIV viremia (2008) (2)
- Antiretroviral Drugs Associated with Chronic ALT Elevations in Persons without HCV and HBV Infection (2015) (2)
- Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs (2016) (2)
- Epigenetic ageing accelerates before antiretroviral therapy and decelerates after viral suppression in people with HIV in Switzerland: a longitudinal study over 17 years (2023) (1)
- Hyaluronic Acid as a Prognostic Marker of Hepatic Encephalopathy and Liver-related Death in HIV/Viral Hepatitis Coinfected Patients (2009) (1)
- Serious Fatal and Non-Fatal Non-AIDS D efining Illnesses (non-ADI) in Europe (2009) (1)
- Correction: Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing Regimens (2013) (1)
- [Antimicrobial resistance among E. coli in urinary specimens: prevalence data from three laboratories in Zurich between 1985 and 2010]. (2012) (1)
- Time to virological failure of three classes of antiretrovirals after initiation of HAART : Results from the EuroSIDA study group (2004) (1)
- Prevalence and risk factors of late presentation for HIV diagnosis and care in a tertiary referral centre in Switzerland Presenting late with HIV-1 (1)
- Prediction of benzimidazole therapy duration with PET/CT in inoperable patients with alveolar echinococcosis (2022) (1)
- Data linkage to evaluate the long-term risk of HIV infection in individuals seeking post-exposure prophylaxis (2021) (1)
- Risk of Bacterial, Viral, and Fungal Infections in Patients With Solid Malignant Tumors Treated With Curative Intent Radiation Therapy (2022) (1)
- Imaging characteristics and diagnostic accuracy of FDG-PET/CT, contrast enhanced CT and combined imaging in patients with suspected mycotic or inflammatory abdominal aortic aneurysms (2022) (1)
- The doctor in his social aspect (2004) (1)
- Prevalence of HIV antibodies among prostitutes in Zürich, Switzerland (1987) (1)
- Polygenic Risk Scores for Prediction of Subclinical Coronary Artery Disease in Persons Living with HIV: The Swiss HIV Cohort Study. (2022) (1)
- Risk Factors for Incident Vascular Graft Infections (2017) (1)
- Impact of unknown incidental findings in PET/CT examinations of patients with proven or suspected vascular graft or endograft infections (2021) (1)
- Changes in Renal Function after Switching from TDF to TAF in HIV-Infected Individuals: A Prospective Cohort Study (2019) (1)
- Prediction of Radiation-induced Lymphopenia following Exposure of the Thoracic Region and Associated Risk of Infections and Mortality (2023) (1)
- Telomere Length Declines In Persons Living With HIV Before Antiretroviral Therapy Start But Not After Viral Suppression: A Longitudinal Study Over >17 Years (2021) (1)
- Impact of Delaying Antiretroviral Treatment during Primary HIV Infection on Telomere Length. (2021) (1)
- [The Swiss HIV Cohort Study--a link between clinical research and medical practice]. (1998) (1)
- Incidence of disseminated histoplasmosis in HIV-infected patients in Switzerland. (1996) (1)
- Coronary Artery Disease-associated and Longevity-associated Polygenic Risk Scores for Prediction of Coronary Artery Disease Events in Persons Living with HIV: The Swiss HIV Cohort Study. (2021) (1)
- Impact of Lamivudine on the Risk of Liver-Related Death in 2,041 Hbsag- and HIV-Positive Individuals: Results from An Inter-Cohort Analysis (2005) (1)
- Changes in alanine aminotransferase levels after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) in HIV‐positive people without viral hepatitis in the Swiss HIV Cohort Study (2021) (1)
- Factors associated with the emergence of K 65 R in HIV-1 infected patients treated with combination antiretroviral therapy containing tenofovir (2009) (1)
- A Lower CD4 Count Predicts Most Causes of Death except Cardiovascular Deaths. The Austrian HIV Cohort Study (2021) (0)
- Open wounds and rifampicin therapy are associated with rifampicin resistance among staphylococcal vascular graft/endograft infections (2021) (0)
- Incidence of drug resistance in patients initiating combination anti retroviral therapy with lopinavir or efavirenz - results from a data-driven simulation (2010) (0)
- Abstract 30, 10th International Workshop on HIV, Madrid, Spain (2006) (0)
- Multi-nucleoside/nucleotide Resistance Mutations 69 Insertion and Q151M and their Impact on Clinical Outcome in the Swiss HIV Cohort Study (2011) (0)
- Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study (2015) (0)
- Reply to Kuniholm et al (2010) (0)
- [HTLV-III antibodies and risk factors for healthy homosexuals in Zurich]. (1985) (0)
- Letter to the Editor Amebiasis Deaths in the United States (2012) (0)
- Causes of Death in Patients Treated with ART, 1996 to 2006: Collaborative Analysis of 13 Cohort Studies (2009) (0)
- P1.02 Analysis of Percutaneous Exposures to Blood and Body Fluids in a Swiss Tertiary Care Medical Center (2006) (0)
- [The Swiss HIV Cohort Study--multifaceted network supporting patient care as well as large international research projects]. (2004) (0)
- OC-0278 Radiation-induced lymphopenia: Fractionation effect and association with infections and mortality. (2019) (0)
- Chronic kidney disease and exposure to antiretroviral drugs in a large cohort with long-term follow-up : the EuroSIDA Study (2010) (0)
- 82. Incidence rates of invasive aspergillosis among lung transplant recipients in timeperiods with universal and targeted antifungal prophylaxis - a nationwide cohort study (2022) (0)
- A comparison of estimated glomerular filtration rates (eGFRs) using Cockcroft-Gault (CG) and the CKD-EPI estimating equations (2013) (0)
- O331 Patterns of viral suppression on cART as predictors of uncontrolled viremia after starting a new antiretroviral after 1 January 2003 (2008) (0)
- Neurocognitive course at two-year follow-up in the neurocognitive assessment in the metabolic and aging cohort (NAMACO) study. (2021) (0)
- Mortality rates according to initial HAART regimen: a collaborative analysis of 12 prospective cohort studies (2005) (0)
- Rates of viral suppression and regimen change according to initial HAART regimen: a collaborative analysis of 12 prospective cohort studies (2005) (0)
- Eleventh International Congress on Drug Therapy in HIV Infection (2012) (0)
- Eleventh International Congress on Drug Therapy in HIV Infection (2012) (0)
- Abstract 588, 16th Conference on Retroviruses and Opportunistic Infections, Montreal, USA (2009) (0)
- [The HIV-antibody positive patient in general practice. Guidelines for rational diagnosis and treatment]. (1986) (0)
- [The prognostic value of different patterns of change in the CD4 lymphocyte counts in 420 symptom-free HIV-1-infected persons]. (1993) (0)
- Age and CD4 count increase on cART: a look beyond the effect of older age on the average CD4 recovery to acquire additional insight on the phenomenon (2013) (0)
- Multidrug-resistant bacteria in travellers hospitalized abroad: prevalence, characteristics, and influence on (2012) (0)
- Prospective evaluation of radiographic manifestations of tuberculosis in relationship with CD4 count in patients with HIV/AIDS (2023) (0)
- Leukocyte Count and Coronary Artery Disease Events in People with HIV: A Longitudinal Study. (2023) (0)
- Follow-up PET/CT of alveolar echinococcosis: Comparison of metabolic activity and immunodiagnostic testing (2022) (0)
- Upgraded Cobas TaqMan version 2: hidden consequences at cohort level (2012) (0)
- Comparison of resistance profiles between patients starting nevirapine and efavirenz in EuroSIDA (2005) (0)
- Hepatitis C Virus (HCV) Coinfection Does Not Influence the CD 4 Cell Recovery in HIV-1 Infected Patients with Maximum Virologic Suppression within the EuroSIDA Cohort (2008) (0)
- Effects of interferon-g treatment on anti-HIV-1 intrinsic immunity in vivo 3 4 (2013) (0)
- Usefulness of 18F-FDG-PET/CT in Therapy Control of Inflammatory and Mycotic Aneurysms (2019) (0)
- Chronic kidney disease in patients with normal eGFR at baseline: results from EuroSIDA (2010) (0)
- 1008-187 Effect of pravastatin on endothelial function in human immunodeficiency virus-infected persons on protease inhibitor-containing antiretroviral combination therapy (2004) (0)
- Reply to Chang and Garcia-Pagan (2010) (0)
- [Tuberculin test, antitubercular chemoprophylaxis and incidence of tuberculosis in a Swiss HIV cohort study]. (1997) (0)
- Usefulness of 18F-FDG-PET/CT and Contrast-enhanced CT for Diagnosis of Mycotic Aneurysms (2019) (0)
- Tracing HIV-1 strains that imprint broadly neutralizing antibody responses (2018) (0)
- Trastuzumab resistance: Bringing tailored therapy to the clinic (2008) (0)
- Trastuzumab resistance: Bringing tailored therapy to the clinic (2008) (0)
- Ambiguity in population-based sequencing of HIV-1 as a marker for the age of HIV infection (2010) (0)
- [The natural history and laboratory parameters of HIV infection]. (1989) (0)
- Machine learning can identify newly diagnosed patients with CLL at high risk of infection (2020) (0)
- International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK (2014) (0)
- International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK (2014) (0)
- Immunophenotypic characterization of TCR γδ T cells and MAIT cells in HIV-infected individuals developing Hodgkin’s lymphoma (2021) (0)
- Human immunodeficiency virus-specific T lymphocyte cell (2001) (0)
- Hyperglycaemia and pharmacokinetics of rifampicin/isoniazid among TB-HIV co-infected patients in Kampala, Uganda. (2020) (0)
- Mutation at reverse transcriptase codon 214 is antagonist to thymidine analogue mutations (TAM) type 2 profiles and predicts virological response to thymidine analogue-containing cART regimens only if TAM type 1 profiles are concomitantly detected (2006) (0)
- P6.24 The financial incentive to market secondary patent of ritonavir and lopinavir/ritonavir (2017) (0)
- Estimation of percentage of HIV-infected people with limited future drug options in a closed observational setting over the period 2007-2011 and beyond (2013) (0)
- PO-1817: Kinetics and dose-volume effect of radiotherapy on leucocyte and platelet blood cell components (2020) (0)
- Hepatitis B (HBV) in the EuroSIDA Cohort: prevalence and impact on mortality, AIDS progession and response to HAART (2003) (0)
- Perioperative antibiotic prophylaxis has no effect on time to positivity and proportion of positive samples: a cohort study of 64 bone and joint infections. (2017) (0)
- [HIV serological parameters in the prognosis and follow-up assessment of an HIV infection]. (1988) (0)
- Response to ®rst protease inhibitor- and efavirenz- containing antiretroviral combination therapy The Swiss HIV Cohort Study (2001) (0)
- Review of the pilot of a new data collection system to investigate causes of death in HIV: the CoDe (coding of Death) project (2005) (0)
- DISCOVER WILEY'S LEADING STATISTICS JOURNALS (2014) (0)
- Prediction of benzimidazole therapy duration with PET/CT in inoperable patients with alveolar echinococcosis (2022) (0)
- Treating drug misuse helps in HIV. (1991) (0)
- Web-based Supplementary Materials for ”Dynamic models for estimating the effect of HAART on CD4 in observational studies: application to the Aquitaine Cohort study and the Swiss HIV Cohort Study” (2016) (0)
- Good Early Results of Negative Pressure Wound Nonexcisional Treatment for Prosthetic Graft Infection Are Durable: It Is a Game Changer: IF11. (2018) (0)
- Prevalence and Predictors for Homo-and Heterosubtypic Antibodies Against In fl uenza A Virus (2014) (0)
- Intrinsic Anti-HIV-1 Immunity Effects of Alpha Interferon Treatment on (2014) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Bruno Ledergerber?
Bruno Ledergerber is affiliated with the following schools:
